基本信息
浏览量:158
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
As C-Level Executive and Chief Medical Officer in the pharmaceutical industry with a profound medical backround in Anesthesiology and Intensive Care Medicine, I provide pragmatic solutions by harmonizing business challenges with medical needs.
My expertise and 25-years experience in Healthcare and global Life Sciences include but are not restricted to:
- Extensive knowledge in Perioperative Medicine, Pharma, Nutrition, and MedTech
- Strategy development and execution
- Process optimization
- Financial planning and steering
- Medical innovation management (7 patents) coupled with a growth mindset
- Leadership in functionally and culturally diverse teams
- Organizational transformation to create high-performance teams
- Change management
- Preclincal drug development & clinical phase I-IV studies
- Safety in clinical trials, data management and statistics
- Medical-scientific affairs including training and education, global event planning and execution
- Regulatory affairs including interactions with regulatory authorities on a global scale
- Strategic understanding of the ongoing global digitization
- Product registration and launch
- Pharmacovigilance deferral procedures
- Key opinion leader (KOL) management
- Solution-oriented business coaching
- Negotiation skills targeting to create win-win situations
- Due diligence
- Sustainability
- Clinical education in Anesthesiology and Intensive Care Medicine
- Team lead in diverse clinical disciplines and ICU
- Medical writing and publishing (200+ peer-reviewed publications)
My expertise and 25-years experience in Healthcare and global Life Sciences include but are not restricted to:
- Extensive knowledge in Perioperative Medicine, Pharma, Nutrition, and MedTech
- Strategy development and execution
- Process optimization
- Financial planning and steering
- Medical innovation management (7 patents) coupled with a growth mindset
- Leadership in functionally and culturally diverse teams
- Organizational transformation to create high-performance teams
- Change management
- Preclincal drug development & clinical phase I-IV studies
- Safety in clinical trials, data management and statistics
- Medical-scientific affairs including training and education, global event planning and execution
- Regulatory affairs including interactions with regulatory authorities on a global scale
- Strategic understanding of the ongoing global digitization
- Product registration and launch
- Pharmacovigilance deferral procedures
- Key opinion leader (KOL) management
- Solution-oriented business coaching
- Negotiation skills targeting to create win-win situations
- Due diligence
- Sustainability
- Clinical education in Anesthesiology and Intensive Care Medicine
- Team lead in diverse clinical disciplines and ICU
- Medical writing and publishing (200+ peer-reviewed publications)
研究兴趣
论文共 316 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Valentin Faerber, Katharina S. Kuhn,Liliana Garneata,Kamyar Kalantar-Zadeh,Sahir Kalim,Dominic S. Raj,Martin Westphal
NUTRIENTSno. 16 (2023): 3503-3503
JOURNAL OF SURGICAL RESEARCH (2023): 1-12
Anästhesie Nachrichtenno. 3 (2022): 211-213
Katharina Thomas,Lisa Zondler,Nadine Ludwig,Marina Kardell, Corinna Lüneburg, Katharina Henke,Sina Mersmann,Andreas Margraf,Tilmann Spieker,Tobias Tekath,Ana Velic,Richard Holtmeier,
Clementina Duran Palma,Musawenkosi Mamba,Johan Geldenhuys,Oluwafolajimi Fadahun,Rolf Rossaint, Kai Zacharowski, Martin Brand,Óscar Díaz-Cambronero,Javier Belda,Martin Westphal,Ute Brauer, Dirk Dormann,
British journal of anaesthesiano. 6 (2020): 847-849
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn